Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats

doi:10.1053/gast.1996.v110.pm8566596

Gastroenterology

Volume 110, Issue 2, February 1996, Pages 489-497

https://doi.org/10.1053/gast.1996.v110.pm8566596 Get rights and content

Abstract

BACKGROUND & AIMS: The trefoil factors, a family of proteins abundantly expressed in gastrointestinal mucous cells, protect the epithelium in vitro. This study determines the effects of exogenously administered trefoil peptides on experimental injury in rats in vivo. METHODS: Gastric injury was induced by either intragastric absolute ethanol (1.0 mL) or subcutaneous indomethacin (20 mg/kg). Recombinant human spasmolytic polypeptide (rHSP) or rat intestinal trefoil factor (ITF) were administered at different doses and time points before or after injury. Vehicle or bovine serum albumin was used as control. The pH of the stomach contents was assessed when the rats were killed. Gastric injury was blindly evaluated macroscopically and histologically. Serum levels of rHSP and ITF were determined by an enzyme-linked immunosorbent assay. RESULTS: Oral rHSP and ITF markedly protected against both ethanol- and indomethacin-induced gastric injury (P < 0.005 at doses of 1-15 mg/rat) when given up to 2 hours before injury; no protection was noted by intraperitoneal rHSP against ethanol injury. Intraperitoneal rHSP protected against indomethacin-induced injury only at the maximal dose given (15 mg). Neither rHSP nor ITF altered gastric pH. Protection was not associated with systemic absorption of trefoil peptides. CONCLUSIONS: Topical trefoil peptides protect the gastric mucosa against ethanol- and indomethacin-induced gastric injuries. These peptides contribute to surface mucosal defense. (Gastroenterology 1996 Feb;110(2):489-97)

References (0)

Cited by (259)

Possible application of trefoil factor family peptides in gastroesophageal reflux and Barrett's esophagus
2019, Peptides
Gastroesophageal reflux disease (GERD) is a chronic disorder of the digestive tract characterised mainly by a heartburn. Being one of the most common gastrointestinal diseases, the prevalence of GERD reaches up to 25.9% in Europe. Barrett’s esophagus (BE) is an acquired condition characterized by the replacement of the normal stratified squamous epithelium with metaplastic columnar epithelium. BE is believed to develop mainly from chronic GERD and is the most important risk factor of esophageal adenocarcinoma. Despite the availability of drugs such as proton pomp inhibitors and antacids, GERD is still a burden to local economy and impairs health-related quality of life in patients. Also, the endoscopic surveillance in patients with BE is burdensome and expensive what drives the need for biomarker of intestinal metaplasia and dysplasia. Trefoil factor family (TFF), consisting of TFF1, TFF2 and TFF3 peptides is gaining more and more attention due to its unique biochemical features and numerous functions. In this review the role of TFF1, TFF2 and TFF3 as potential treatment option and/or biomarker in the upper GI tract is discussed with particular focus on GERD and BE.
Pathophysiological Mechanisms of Gastrointestinal Toxicity
2018, Comprehensive Toxicology: Third Edition
Humans swallow a great variety and often large amounts of chemicals as nutrients, incidental food additives and contaminants, drugs, and inhaled particles and chemicals, thus exposing the gastrointestinal tract to many potentially toxic substances. It serves as a barrier in many cases to protect other components of the body from such substances and infections. Fortunately, the gastrointestinal tract is remarkably robust and generally is able to withstand multiple daily assaults by the chemicals to which it is exposed. Some chemicals, however, can affect one or more aspects of the gastrointestinal tract to produce abnormal events that reflect toxicity. It is the purpose of this chapter to evaluate the mechanisms by which toxic chemicals produce their deleterious effects and to determine the consequences of the toxicity on integrity of gastrointestinal structure and function. Probably because of the intrinsic ability of the gastrointestinal tract to resist toxic chemicals, there is a paucity of data regarding gastrointestinal toxicology. It is therefore necessary in many cases to extrapolate toxic mechanisms from infectious processes, inflammatory conditions, ischemia, and other insults in addition to more conventional chemical sources of toxicity.
In vivo prophylactic gastroprotection using α-bisabolol encapsulated in lipid-core nanocapsules and in cocoa-theospheres
2016, Journal of Drug Delivery Science and Technology
This study describes the development of α-bisabolol-loaded lipid-core nanocapsules (α-BLNC) and Cocoa-theospheres (α-BCT), aiming oral use for gastroprotection. α-Bisabolol was efficiently encapsulated in high drug loading (25%) in lipid-core nanocapsules and cocoa-theospheres. Laser diffraction analysis showed nanometric and unimodal distributions (mean diameters of 216 and 148 nm, respectively). The gastroprotective indexes in rats for the ethanol-induced ulcers were 0.11 (α-BCT), 0.68 (blank-CT), 0.29 (α-BLNC) and 0.37 (blank-LNC), while for the indomethacin-induced ulcer model, the results were 37.33 (α-BCT), 48.14 (blank-CT), 31.33 (α-BLNC) and 45.33 (blank-LNC). SEM analysis of the stomach mucosa showed more homogenous and cohesive coatings for α-BLNC and α-BCT treatments in comparison with the blank formulations. In histological evaluations, protection against the tissue damage and Periodic Acid-Schiff-positive increase were observed after the pretreatment with α-bisabolol nanoparticles in ethanol and indomethacin-induced ulcers. α-Bisabolol-loaded in cocoa-theospheres provided a gastroprotective effect absent in blank-cocoa-theospheres, while the drug-loaded lipid-core nanocapsules maintained the gastroprotective effect observed for blank lipid-core nanocapsules, which are per se antioxidant agents. The nanoencapsulation enabled a dose reduction of α-bisabolol. Moreover, lipid-core nanocapsules and cocoa-theospheres have mucoadhesive properties even though they present diverse supramolecular structures. Both lipid-core nanocapsules and cocoa-theospheres are promising platforms for the development of prophylactic formulations.
MiR218-5p regulates the proliferation of gastric cancer cells by targeting TFF1 in an Erk1/2-dependent manner
2015, Biochimica et Biophysica Acta - Molecular Basis of Disease
Trefoil factor 1 (TFF1), a member of the trefoil peptide family, is not only associated with mucosal protection and restoration but is also correlated with tumorigenesis of the gastrointestinal tract. In an early study, we performed sequence analysis and identified one potential miR423-5p binding site within the 3′-untranslated region of TFF1 using microRNA target prediction tools. In the current study, we demonstrated that the coding DNA region within TFF1 is also a candidate for miR218-5p targeting. We used real-time PCR and in situ hybridization to analyze the correlation between miR218-5p and TFF1 expression in tumor lesions and paracancerous tissue in gastric cancer (GC) samples. Additionally, endogenous and exogenous TFF1 were suppressed by miR218-5p in gastric cancer cells and influenced the progression of GC in an Erk1/2-dependent manner. Targeting miR218-5p may provide a novel strategy for the treatment of GC.
Emerging strategy towards mucosal healing in inflammatory bowel disease: what the future holds?
2023, Frontiers in Immunology
C/EBPα Epigenetically Modulates TFF1 Expression via mC-6 Methylation in the Jejunum Inflammation Induced by a Porcine Coronavirus
2022, Frontiers in Immunology

View all citing articles on Scopus

View full text